These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ETV6, TEL/ABL, 2120, ENSG00000139083, P41212, TEL
59 results:

  • 1. Right vs. Left colorectal cancer - Where do we draw the line?
    Lansom J; Liew I; Ng KS; Ly T; Naidu K; Chapuis P; Chan C
    Hum Pathol; 2024 Sep; 151():105634. PubMed ID: 39117025
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The effect of ileal resection length on postoperative complications and prognosis in right colon cancer.
    Yıldırım M; Kocabay A; Koca B; Saglam AI; Ozkan N
    Langenbecks Arch Surg; 2024 Jul; 409(1):206. PubMed ID: 38967821
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Neurotrophic tyrosine receptor kinase gene fusions in adult and pediatric patients with solid tumors: a clinicogenomic biobank and record linkage study of expression frequency and patient characteristics from Finland.
    Zhang W; Schmitz AA; Kallionpää RE; Perälä M; Pitkänen N; Tukiainen M; Alanne E; Jöhrens K; Schulze-Rath R; Farahmand B; Zong J
    Acta Oncol; 2024 Jul; 63():542-551. PubMed ID: 38967220
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Survival and safety after neoadjuvant chemotherapy or upfront surgery for locally advanced colon cancer: meta-analysis.
    Aliseda D; Arredondo J; Sánchez-Justicia C; Alvarellos A; Rodríguez J; Matos I; Rotellar F; Baixauli J; Pastor C
    Br J Surg; 2024 Jan; 111(2):. PubMed ID: 38381934
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Structure-activity relationship study of 1,6-naphthyridinone derivatives as selective type II AXL inhibitors with potent antitumor efficacy.
    Zhuo L; Guo M; Zhang S; Wu J; Wang M; Shen Y; Peng X; Wang Z; Jiang W; Huang W
    Eur J Med Chem; 2024 Feb; 265():116090. PubMed ID: 38169272
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Small extrachromosomal circular DNAs as biomarkers for multi-cancer diagnosis and monitoring.
    Luo X; Zhang L; Cui J; An Q; Li H; Zhang Z; Sun G; Huang W; Li Y; Li C; Jia W; Zou L; Zhao G; Xiao F
    Clin Transl Med; 2023 Sep; 13(9):e1393. PubMed ID: 37649244
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Patterns of emergency department visits before diagnosis with digestive neuroendocrine neoplasms.
    Abdel-Rahman O; Ghosh S
    Int J Colorectal Dis; 2023 May; 38(1):148. PubMed ID: 37253995
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Elaboration of NTRK-rearranged colorectal cancer: Integration of immunoreactivity pattern, cytogenetic identity, and rearrangement variant.
    Wu S; Liu Y; Shi X; Zhou W; Zeng X
    Dig Liver Dis; 2023 Dec; 55(12):1757-1764. PubMed ID: 37142453
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Impact of the COVID-19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race.
    Berrian J; Liu Y; Ezenwajiaku N; Moreno-Aspitia A; Holton SJ; Toriola AT; Colditz GA; Housten AJ; Hall L; Fiala MA; Ademuyiwa FO
    Cancer Med; 2023 Mar; 12(6):7381-7388. PubMed ID: 36404491
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prevalence of NTRK Fusions in Canadian Solid Tumour cancer Patients.
    Silvertown JD; Lisle C; Semenuk L; Knapp C; Jaynes J; Berg D; Kaul N; Lachapelle J; Richardson L; Speevak M; Sarras H; Berman DM; Carter R; Feilotter H; Feltis T
    Mol Diagn Ther; 2023 Jan; 27(1):87-103. PubMed ID: 36194351
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Pan-tropomyosin receptor kinase immunohistochemistry is a feasible routine screening strategy for NTRK fusions in mismatch repair-deficient colorectal carcinomas.
    Zhang Z; Pang J; Chen L; Chen J; Li J; Liu H; Wang J; Wu H; Liang Z
    Hum Pathol; 2022 Nov; 129():21-31. PubMed ID: 35977594
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions.
    Kim JH; Hong JH; Choi YL; Lee JA; Seo MK; Lee MS; An SB; Sung MJ; Cho NY; Kim SS; Shin YK; Kim S; Kang GH
    J Pathol; 2021 Dec; 255(4):399-411. PubMed ID: 34402529
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The platelet to lymphocyte ratio is a potential inflammatory marker predicting the effects of adjuvant chemotherapy in patients with stage II colorectal cancer.
    Fu Y; Chen X; Song Y; Huang X; Chen Q; Lv X; Gao P; Wang Z
    BMC Cancer; 2021 Jul; 21(1):792. PubMed ID: 34238262
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. VGLL4 with low YAP expression is associated with favorable prognosis in colorectal cancer.
    Kim JY; Kim EK; Lee WM; Hong YO; Lee H
    APMIS; 2020 Oct; 128(10):543-551. PubMed ID: 32794608
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prognostic factors and patterns of recurrence after emergency management for obstructing colon cancer: multivariate analysis from a series of 2120 patients.
    Manceau G; Voron T; Mege D; Bridoux V; Lakkis Z; Venara A; Beyer-Berjot L; Abdalla S; Sielezneff I; Lefèvre JH; Karoui M;
    Langenbecks Arch Surg; 2019 Sep; 404(6):717-729. PubMed ID: 31602503
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Positive effect of single nucleotide RAD51 135G>C polymorphism and low Ku70 protein expression on female rectal cancer patients survival after preoperative radiotherapy.
    Gasinska A; Biesaga B; Widla AJ; Darasz Z
    Turk J Gastroenterol; 2019 Jan; 30(1):3-14. PubMed ID: 30289394
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Mediterranean dietary components are inversely associated with advanced colorectal polyps: A case-control study.
    Fliss-Isakov N; Kariv R; Webb M; Ivancovsky D; Margalit D; Zelber-Sagi S
    World J Gastroenterol; 2018 Jun; 24(24):2617-2627. PubMed ID: 29962818
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Evidence-based quality standards improve prognosis in colon cancer care.
    Trautmann F; Reißfelder C; Pecqueux M; Weitz J; Schmitt J
    Eur J Surg Oncol; 2018 Sep; 44(9):1324-1330. PubMed ID: 29885983
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions.
    Hechtman JF; Benayed R; Hyman DM; Drilon A; Zehir A; Frosina D; Arcila ME; Dogan S; Klimstra DS; Ladanyi M; Jungbluth AA
    Am J Surg Pathol; 2017 Nov; 41(11):1547-1551. PubMed ID: 28719467
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours.
    Coyle C; Cafferty FH; Rowley S; MacKenzie M; Berkman L; Gupta S; Pramesh CS; Gilbert D; Kynaston H; Cameron D; Wilson RH; Ring A; Langley RE;
    Contemp Clin Trials; 2016 Nov; 51():56-64. PubMed ID: 27777129
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.